by Clinical Neuropsychologist Online | Tuesday, July 14, 2026 | Dementia
Abstract INTRODUCTION Up to 90% of Down syndrome (DS) patients develop Alzheimer’s disease (AD). Sleep disturbance, affecting over 75% of DS patients, is implicated in AD pathogenesis. The thalamus, central to sleep and arousal, shows early vulnerability in...
by Clinical Neuropsychologist Online | Tuesday, July 14, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 7, July 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 14, 2026 Neuro-Dementia Previous...
by Clinical Neuropsychologist Online | Tuesday, July 14, 2026 | Dementia
Abstract INTRODUCTION Individuals with Down syndrome (DS) face high risk for Alzheimer’s disease (AD), yet presymptomatic detection of cognitive decline is hindered by lifelong intellectual disability. METHODS Using data from the Alzheimer’s Biomarker...
by Clinical Neuropsychologist Online | Tuesday, July 14, 2026 | Dementia
Abstract BACKGROUND The study aim is to investigate whether blood biomarkers (BBMs) of Alzheimer’s disease (AD) pathology are associated with postoperative cognitive dysfunction (POCD) after cardiac surgery. METHODS Cognitive performance was assessed before and...
by Clinical Neuropsychologist Online | Tuesday, July 14, 2026 | Dementia
Abstract INTRODUCTION We investigated heterogeneity in the association between cumulative heat exposure and cognitive decline among older Japanese adults. METHODS We analyzed 33,877 adults aged ≥ 65 years from a nationwide cohort (2010–2023) linked with long-term care...
by Clinical Neuropsychologist Online | Tuesday, July 14, 2026 | Dementia
Abstract INTRODUCTION Metabolic syndrome (MetS) is associated with increased dementia risk, but its relationship with brain aging is unclear. METHODS The study included 27,375 UK Biobank participants aged 40 to 70 years. MetS was defined as having at least three of...
